Rhumbline Advisers Sells 38,426 Shares of The Campbell’s Company $CPB

Rhumbline Advisers trimmed its holdings in shares of The Campbell’s Company (NASDAQ:CPB) by 7.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 483,059 shares of the company’s stock after selling 38,426 shares during the period. Rhumbline Advisers’ holdings in Campbell’s were worth $15,255,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. SBI Securities Co. Ltd. grew its stake in Campbell’s by 66.8% in the second quarter. SBI Securities Co. Ltd. now owns 961 shares of the company’s stock valued at $29,000 after purchasing an additional 385 shares in the last quarter. Geneos Wealth Management Inc. boosted its holdings in shares of Campbell’s by 333.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 975 shares of the company’s stock valued at $39,000 after buying an additional 750 shares during the last quarter. Parvin Asset Management LLC acquired a new stake in shares of Campbell’s in the 2nd quarter valued at approximately $35,000. Kentucky Trust Co grew its stake in shares of Campbell’s by 40.0% in the third quarter. Kentucky Trust Co now owns 1,400 shares of the company’s stock valued at $44,000 after buying an additional 400 shares in the last quarter. Finally, Country Trust Bank acquired a new position in Campbell’s during the second quarter worth $46,000. Institutional investors and hedge funds own 52.35% of the company’s stock.

Insider Transactions at Campbell’s

In related news, EVP Anthony Sanzio sold 2,700 shares of the firm’s stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $26.51, for a total transaction of $71,577.00. Following the transaction, the executive vice president directly owned 25,264 shares of the company’s stock, valued at approximately $669,748.64. This trade represents a 9.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Charles A. Brawley III sold 11,550 shares of the business’s stock in a transaction dated Tuesday, December 30th. The shares were sold at an average price of $28.14, for a total transaction of $325,017.00. Following the completion of the sale, the executive vice president directly owned 43,777 shares of the company’s stock, valued at $1,231,884.78. This represents a 20.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 19.78% of the company’s stock.

Campbell’s Trading Down 0.9%

Shares of NASDAQ:CPB opened at $27.53 on Thursday. The Campbell’s Company has a 12-month low of $25.62 and a 12-month high of $43.85. The business has a 50 day moving average of $27.70 and a 200-day moving average of $30.19. The company has a quick ratio of 0.34, a current ratio of 0.82 and a debt-to-equity ratio of 1.54. The stock has a market cap of $8.21 billion, a PE ratio of 14.26, a P/E/G ratio of 9.75 and a beta of -0.04.

Campbell’s (NASDAQ:CPB) last released its quarterly earnings results on Tuesday, December 9th. The company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.04. Campbell’s had a return on equity of 21.84% and a net margin of 5.69%.The business had revenue of $2.68 billion during the quarter. Campbell’s’s quarterly revenue was down 3.4% on a year-over-year basis. Campbell’s has set its FY 2026 guidance at 2.400-2.550 EPS. As a group, equities research analysts forecast that The Campbell’s Company will post 3.15 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have commented on the stock. Weiss Ratings cut shares of Campbell’s from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, January 5th. Morgan Stanley dropped their target price on shares of Campbell’s from $30.00 to $28.00 and set a “cautious” rating on the stock in a report on Friday, January 16th. UBS Group cut their target price on shares of Campbell’s from $28.00 to $26.00 and set a “sell” rating for the company in a research note on Wednesday, December 10th. Stephens lowered their price target on Campbell’s from $40.00 to $38.00 and set an “overweight” rating on the stock in a research report on Monday, December 8th. Finally, Barclays set a $27.00 price objective on Campbell’s in a research note on Friday, January 16th. Three equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and six have given a Sell rating to the company. According to data from MarketBeat, Campbell’s has an average rating of “Reduce” and a consensus target price of $32.29.

About Campbell’s

Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.

The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.